Valion Bio (VBIO) Stock Analysis
NASDAQHealthcareBiotechnology
What Valion Bio does
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Key metrics
ETFs linked to VBIO
Broad-market and Healthcare sector ETFs an investor holding Valion Bio is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how VBIO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze VBIO in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Valion Bio?
- Valion Bio trades under the ticker VBIO on NASDAQ.
- Which exchange is VBIO listed on?
- VBIO is listed on NASDAQ.
- What sector does Valion Bio operate in?
- Valion Bio is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze VBIO in a portfolio?
- PortView shows VBIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.